Curia Expands Glasgow Manufacturing Capacity and Enhances Cell Line Development Platform

2026-03-19 - 13:10

The Glasgow, UK, site is well known throughout the industry for its more than 25 years of experience with formulation, lyophilization development and sterile fill-finish capabilities, including ADCs and other highly potent products. The current expansion is expected to be completed by early 2027. The investment will add an Annex 1 compliant isolator-based vial filling line and lyophilizer. Once complete, Glasgow will be able to fill batches up to 20,000 vials and will be well‐positioned to support future small‐scale commercial fills. Read More